Page 1 of Clinical Trials for ( Drugs AND Investigational ), 44432 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Single Dose Escalation First Time in Human PK Study
Last Updated: January 27, 2011
Condition(s): Healthy Subjects; Infections, Bacterial
2
Terminated
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Last Updated: March 13, 2007
Condition(s): Colorectal Neoplasms; Diarrhea
3
Completed
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
Last Updated: March 17, 2011
Condition(s): Carcinoma Breast Stage IV; Neoplasms, Breast
4
Completed
A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
Last Updated: January 7, 2008
Condition(s): Anxiety Disorder
5
Not yet recruiting
Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
Last Updated: May 21, 2012
Condition(s): Tuberculosis
6
Terminated
The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
Last Updated: December 10, 2009
Condition(s): Alzheimer Disease
7
Completed
Experimental Medication For the Treatment of Generalized Anxiety Disorder
Last Updated: January 7, 2008
Condition(s): Anxiety Disorder
8
Completed
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
Last Updated: June 23, 2005
Condition(s): Multiple Myeloma
9
Completed
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Last Updated: June 23, 2005
Condition(s): Breast Neoplasms; Breast Cancer; Metastasis
10
Completed
A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)
Last Updated: August 15, 2007
Condition(s): HIV Infections
11
Completed
A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
Last Updated: January 24, 2011
Condition(s): HIV Infection
12
Completed
An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
Last Updated: October 20, 2011
Condition(s): Epilepsy
13
Recruiting
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
14
Active, not recruiting
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Last Updated: January 5, 2012
Condition(s): HIV Infection; Infection, Human Immunodeficiency Virus
15
Recruiting
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Last Updated: December 21, 2011
Condition(s): Breast Neoplasms; Breast Cancer; Breast Tumors
16
Completed
Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
Last Updated: March 8, 2011
Condition(s): Diabetes Mellitus, Non-Insulin-Dependent
17
Completed
Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)
Last Updated: February 14, 2012
Condition(s): Carcinoma, Non-Small-Cell Lung; Lung Neoplasms
18
Active, not recruiting
A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy
Last Updated: August 29, 2011
Condition(s): Anaplastic Thyroid Cancer
19
Completed
Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes
Last Updated: February 2, 2010
Condition(s): Type 2 Diabetes
20
Completed
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
Last Updated: March 30, 2012
Condition(s): Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drugs%2C+Investigational

Page 1 of Clinical Trials for ( Drugs AND Investigational ), 44432 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About